English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objectives: The aim of this study is to compare the effect of platelet-rich fibrin (L-PRF) and bone morphogenetic protein-2 (rhBMP-2) in management of medication-related osteonecrosis of jaw (MRONJ). Patients and Methods: Among 35 patients who were diagnosed with MRONJ, 12 patients were treated with L-PRF, 12 patients were treated with rhBMP-2 and 11 patients were treated with both L-PRF and rhBMP-2, evaluation of surgical sites was done for each patient postoperatively at 4 and 16 weeks. Results: At 4 and 16 weeks postoperatively, MRONJ treated with both L-PRF and rhBMP-2 showed favorable outcomes with complete resolution of the lesions than that treated with L-PRF or rhBMP-2 alone. However this difference didn’t reach the level of statistical significance (P=0.42). Conclusion: The simultaneous use of both L-PRF and rhBMP-2 in management of MRONJ is a better treatment modality compared to the single use of each one of them alone.

egyptian dental journal /egyptian dental journal

COMPARISON OF DIFFERENT SURGICAL PROTOCOLS IN MANAGEMENT OF MEDICATION-RELATED OSTEONECROSIS OF THE JAW USING PLATELET-RICH FIBRIN AND BONE MORPHOGENETIC PROTEIN-2